Ceftazidime

Product NDC
25021-127
11-digit product format
250210127
Labeler code
25021
Product ID
25021-127_6b34b5ad-001f-4c39-8415-a223eb692b46
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
ceftazidime
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Labeler
Sagent Pharmaceuticals
Application
ANDA062640
Marketing category
ANDA
Marketing start
2008-05-15
Substance
CEFTAZIDIME
Active strength
1 g/1
Pharmacologic classes
Cephalosporin Antibacterial [EPC], Cephalosporins [CS]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Ceftazidime
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CEFTAZIDIME1 g/1

Harmonized Identifiers#

Field, Values table
FieldValues
Unii9M416Z9QNR
Rxcui1659283, 1659287

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
fb7d24f2-fcd1-4dc6-b9d0-b1f65bfffab5Product name120150409

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
25021-127-20Ceftazidime1 in 1 VIALINJECTION, POWDER, FOR SOLUTION111
25021-127-20Ceftazidime25 in 1 CARTONINJECTION, POWDER, FOR SOLUTION2511

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
25021-127-20EA - Each25021-12721a42dad-cda4-4d28-bd57-33adc07e6c7612012-07-24
25021-127-66EA - Each25021-12744f7f396-7806-414a-8bd4-0e06d8c18e2512015-07-20

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ceftazidimeACTIVE INGREDIENT9M416Z9QNRCEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]6
CEFTAZIDIME ANHYDROUSACTIVE MOIETYDZR1ENT301CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]6
sodium carbonateINACTIVE INGREDIENT45P3261C7TCEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]6

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
25021-127CEFTAZIDIME INJECTION, POWDER, FOR SOLUTION [SAGENT PHARMACEUTICALS]11Current NDC, Legacy NDC, 2 package rows20201007_112c5457-8d71-49f5-b531-9761d7d38c93.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
1659283cefTAZidime 1 GM InjectionPSN112c5457-8d71-49f5-b531-9761d7d38c9311
1659287cefTAZidime 2 GM InjectionPSN112c5457-8d71-49f5-b531-9761d7d38c9311
1659283ceftazidime 1000 MG InjectionSCD112c5457-8d71-49f5-b531-9761d7d38c9311
1659287ceftazidime 2000 MG InjectionSCD112c5457-8d71-49f5-b531-9761d7d38c9311
1659283ceftazidime (as ceftazidime pentahydrate) 1000 MG InjectionSY112c5457-8d71-49f5-b531-9761d7d38c9311
1659287ceftazidime (as ceftazidime pentahydrate) 2000 MG InjectionSY112c5457-8d71-49f5-b531-9761d7d38c9311
1659283ceftazidime 1 GM InjectionSY112c5457-8d71-49f5-b531-9761d7d38c9311
1659287ceftazidime 2 GM InjectionSY112c5457-8d71-49f5-b531-9761d7d38c9311

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
25021-127-202502101272025 VIAL in 1 CARTON (25021-127-20) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL25 vial2008-05-150000-00-00NoNoCurrent
25021-127-662502101276625 VIAL in 1 CARTON (25021-127-66) > 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL25 vial2015-07-010000-00-00NoNoCurrent